Aptadir raises €40M seed to advance RNA demethylating medicines
Milan, Italy — 29 September 2026 — Aptadir Therapeutics announced the closing of a EUR 40M ($45M) seed round led by 4BIO Capital, with follow-on...
This website uses cookies to improve your experience. We assume you agree, but you can opt out if you wish. Accept More Info